Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.22 USD | +4.13% | -2.12% | -17.16% |
Apr. 25 | Top Premarket Gainers | MT |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
Financials (USD)
Sales 2024 * | 24.07M | Sales 2025 * | 42.86M | Capitalization | 57.93M |
---|---|---|---|---|---|
Net income 2024 * | -61M | Net income 2025 * | -40M | EV / Sales 2024 * | 2.41 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.35 x |
P/E ratio 2024 * |
-0.99
x | P/E ratio 2025 * |
-2.32
x | Employees | 69 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.66% |
Latest transcript on Cidara Therapeutics, Inc.
1 day | +4.44% | ||
1 week | -6.69% | ||
Current month | +6.01% | ||
1 month | -21.60% | ||
3 months | -6.63% | ||
6 months | -18.59% | ||
Current year | -20.03% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Preetam Shah
DFI | Director of Finance/CFO | 51 | 21-08-31 |
Les Tari
CTO | Chief Tech/Sci/R&D Officer | 57 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Burgess
CHM | Chairman | 62 | 14-03-31 |
Director/Board Member | 69 | 14-03-31 | |
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 13.15 | +3.58% | 22 216 |
24-05-13 | 12.7 | +4.44% | 14,814 |
24-05-10 | 12.16 | -3.49% | 30,353 |
24-05-09 | 12.6 | -3.45% | 27,810 |
24-05-08 | 13.05 | -2.90% | 17,270 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.03% | 57.93M | |
+5.66% | 111B | |
+11.23% | 105B | |
-0.38% | 21.93B | |
-12.15% | 22.34B | |
-7.66% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- CDTX Stock